Effectiveness of Tranexamic acid in reducing blood loss during myomectomy in federal Medical Centre, Owerri: A randomised controlled trial
- Conditions
- Uterine fibroid
- Registration Number
- PACTR202001691971779
- Lead Sponsor
- Onwukwe Emeka
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 60
1) Consenting women scheduled to have abdominal (laparotomy and ) myomectomy
2) uterine size of 16 weeks and above with multiple uterine fibroids
1) women with known allergy to Tranexamic acid
2) women with current and / or previous thromboembolic disease
3) women with bleeding disorders
4) women taking combine oral contraceptive pills
5) women who had received Gonadotrophin Releasing hormone analogue within three month of the proposed surgery
6) women who are receiving Tranexamic acid for menorrhagia within one month of surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Estimated intraoperative blood loss
- Secondary Outcome Measures
Name Time Method Packed cell volume postoperative;Number of participants requiring blood transfusion;The number of units of whole blood transfused;Duration of sugery